Mount Sinai Researchers Develop First Targeted Therapy for Rare T-Cell Lymphoma Following CAR T Treatment
In a landmark development at the forefront of hematologic oncology, researchers from The Tisch Cancer Institute at the Icahn School ...
In a landmark development at the forefront of hematologic oncology, researchers from The Tisch Cancer Institute at the Icahn School ...
In a remarkable convergence of cutting-edge research and clinical innovation, scientists at The University of Texas MD Anderson Cancer Center ...
In a groundbreaking study conducted in April 2025, researchers have unveiled the transformative potential of a novel technique known as ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine